The role of AKT and NHEJ pathways in the sensitivity of BRCA2-mutated epithelial ovarian cancer to PARP inhibitors

Autor: Xiong, A., Gokyer, D., Shapiro-Franklin, N., Lin, Z.P., Ratner, E.S.
Zdroj: In Gynecologic Oncology October 2020 159 Supplement 1:146-146
Databáze: ScienceDirect